<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03507387</url>
  </required_header>
  <id_info>
    <org_study_id>XYFY2018-KL010-01</org_study_id>
    <nct_id>NCT03507387</nct_id>
  </id_info>
  <brief_title>Preventive Intramuscular Phenylephrine in Elective Cesarean Section Under Spinal Anesthesia</brief_title>
  <official_title>Preventive Intramuscular Phenylephrine in Elective Cesarean Section Under Spinal Anesthesia: A Randomized Controlled Tiral</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal anesthesia is the preferred anesthesia method in cesarean section to provide
      satisfactory analgesia and muscle relaxant with less impact on respiratory system. However,
      hypotension often occurred due to the block of sympathetic nerve, causing maternal decline of
      frontal lobe oxygenation, nausea vomit and the decrease of uteroplacental perfusion. Several
      measures are used to prevent or treat hypotension caused by spinal anesthesia: prehydration,
      limb compression, left lateral tilt of operation tables or usage of vasopressors. In the past
      decade, the most recommended vasopressor to prevent or treat hypotension in spinal anesthesia
      in cesarean section was phenylephrine, an Î±-adrenergic receptor, maintaining maternal blood
      pressure and fetal acid-base state. In clinical work, there are two ways to use phenylephrine
      : intravenous method with less onset time (several seconds and duration (several minutes) and
      intramuscular method with longer onset time (10-15 minutes) and duration (1 hour). Many
      trials demonstrated the protective effect of preventive intravenous phenylephrine on maternal
      hemodynamics and neonatal acid-base status. However, few trials reported the effect of
      preventive intramuscular phenylephrine on cesarean section under spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypotension often occurred in parturients undergoing cesarean section in spinal anesthesia.
      This study aims to determine whether preventive intramuscular phenylephrine can better the
      fetal acid-base state and maternal hemodynamics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">August 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Umbilical artery potential of hydrogen (pH)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous potential of hydrogen (pH)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical artery base excess</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous base excess</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical artery partial pressure of oxygen (PaO2)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous partial pressure of oxygen (PaO2)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical artery partial pressure of carbon dioxide (PaCO2)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous partial pressure of carbon dioxide (PaCO2)</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical artery lactate</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous lactate</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical artery glucose</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical venous glucose</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>detected by a blood gase analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of fetal acidosis</measure>
    <time_frame>after the baby is delivered</time_frame>
    <description>Umbilical artery pH value&lt;7.20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>decrease of systolic blood pressure&gt;20% baseline values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypertension</measure>
    <time_frame>intraoperative</time_frame>
    <description>increase of systolic blood pressure&gt;20% baseline values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of bradycardia</measure>
    <time_frame>intraoperative</time_frame>
    <description>heart rate &lt;50 bpm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nausea or vomit</measure>
    <time_frame>intraoperative</time_frame>
    <description>observed by the anesthesiologist</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Elective Cesarean Section</condition>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Intramuscular phenylephrine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in intramuscular phenylephrine group will receive spinal anesthesia with bupivacaine. 5 mg (1ml) phenylephrine intramuscular injection will be given into the gluteus maximus muscle before anesthesia.1ml of 0.9% normal saline intravenous injection will be given after the subarachnoid injection is completed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous phenylephrine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in intravenous phenylephrine group will receive spinal anesthesia with bupivacaine. 1ml of 0.9% normal saline intramuscular injection will be given into the gluteus maximus muscle before anesthesia.100ug (1ml) phenylephrine intravenous injection will be given after the subarachnoid injection is completed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in intravenous phenylephrine group will receive spinal anesthesia with bupivacaine. 1ml of 0.9% normal saline intramuscular injection will be given into the gluteus maximus muscle before anesthesia. 1ml of 0.9% normal saline intravenous injection will be given after the subarachnoid injection is completed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>5 mg (1ml) phenylephrine intramuscular injection will be given into the gluteus maximus muscle before anesthesia.100ug (1ml) phenylephrine intravenous injection will be given after the subarachnoid injection is completed .</description>
    <arm_group_label>Intramuscular phenylephrine group</arm_group_label>
    <arm_group_label>Intravenous phenylephrine group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Metasympatol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>1ml 0.9% normal saline intramuscular injection will be given into the gluteus maximus muscle before anesthesia and after the subarachnoid injection is completed.</description>
    <arm_group_label>Intramuscular phenylephrine group</arm_group_label>
    <arm_group_label>Intravenous phenylephrine group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Physiological saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>All patients will receive spinal anesthesia with bupivacaine.</description>
    <arm_group_label>Intramuscular phenylephrine group</arm_group_label>
    <arm_group_label>Intravenous phenylephrine group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years to 40 years.

          2. Elective cesarean section

          3. American Society of Anesthesiologists (ASA) grade from I to â¡, height from 150 cm to
             180 cm, BMI&lt;40kg/m2

          4. Singleton pregnancy

          5. Without pregnancy complications

        Exclusion Criteria:

          1. Multiple pregnancy

          2. Preoperative bradycardia

          3. Coagulation dysfunction

          4. Parturients with hypertension, diabetes, eclampsia and other pregnancy complications.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chao Xu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Hospital of Xuzhou Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical University</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Foss VT, Christensen R, Rokamp KZ, Nissen P, Secher NH, Nielsen HB. Effect of phenylephrine vs. ephedrine on frontal lobe oxygenation during caesarean section with spinal anesthesia: an open label randomized controlled trial. Front Physiol. 2014 Mar 3;5:81. doi: 10.3389/fphys.2014.00081. eCollection 2014.</citation>
    <PMID>24624090</PMID>
  </results_reference>
  <results_reference>
    <citation>Macarthur A, Riley ET. Obstetric anesthesia controversies: vasopressor choice for postspinal hypotension during cesarean delivery. Int Anesthesiol Clin. 2007 Winter;45(1):115-32. Review.</citation>
    <PMID>17215703</PMID>
  </results_reference>
  <results_reference>
    <citation>Mon W, Stewart A, Fernando R, Ashpole K, El-Wahab N, MacDonald S, Tamilselvan P, Columb M, Liu YM. Cardiac output changes with phenylephrine and ephedrine infusions during spinal anesthesia for cesarean section: A randomized, double-blind trial. J Clin Anesth. 2017 Feb;37:43-48. doi: 10.1016/j.jclinane.2016.11.001. Epub 2016 Dec 26.</citation>
    <PMID>28235526</PMID>
  </results_reference>
  <results_reference>
    <citation>Thomas DG, Robson SC, Redfern N, Hughes D, Boys RJ. Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth. 1996 Jan;76(1):61-5.</citation>
    <PMID>8672382</PMID>
  </results_reference>
  <results_reference>
    <citation>Lin FQ, Qiu MT, Ding XX, Fu SK, Li Q. Ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean section: an updated meta-analysis. CNS Neurosci Ther. 2012 Jul;18(7):591-7. doi: 10.1111/j.1755-5949.2012.00345.x.</citation>
    <PMID>22759268</PMID>
  </results_reference>
  <results_reference>
    <citation>Mohta M, Aggarwal M, Sethi AK, Harisinghani P, Guleria K. Randomized double-blind comparison of ephedrine and phenylephrine for management of post-spinal hypotension in potential fetal compromise. Int J Obstet Anesth. 2016 Aug;27:32-40. doi: 10.1016/j.ijoa.2016.02.004. Epub 2016 Feb 21.</citation>
    <PMID>27020488</PMID>
  </results_reference>
  <results_reference>
    <citation>Saravanan S, Kocarev M, Wilson RC, Watkins E, Columb MO, Lyons G. Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth. 2006 Jan;96(1):95-9. Epub 2005 Nov 25.</citation>
    <PMID>16311286</PMID>
  </results_reference>
  <results_reference>
    <citation>MagalhÃ£es E, GovÃªia CS, de AraÃºjo Ladeira LC, Nascimento BG, Kluthcouski SM. Ephedrine versus phenylephrine: prevention of hypotension during spinal block for cesarean section and effects on the fetus. Rev Bras Anestesiol. 2009 Jan-Feb;59(1):11-20. English, Portuguese.</citation>
    <PMID>19374211</PMID>
  </results_reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 7, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuzhou Medical University</investigator_affiliation>
    <investigator_full_name>Chao Xu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Intramuscular</keyword>
  <keyword>Phenylephrine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

